Today's News | Note: News feeds may no longer be available for the articles on this page.

Anti-nausea drug safe for fetuses, a study shows 3:42 PM 6/10/2009
Los Angeles Times - CA,USA
The first study of pregnant women taking the anti-nausea drug metoclopramide found that it is safe for both fetus and mother. ...

Pfizer exec reinforces company's generic drug plan 3:32 PM 6/10/2009
Forbes - NY,USA
Pfizer's president of established products told analysts that part of the company's strategy includes focusing on the off-patent marketplace. ...

US FDA panel backs antipsychotic drugs for kids 2:12 PM 6/10/2009
Reuters - USA
The US FDA's panel of outside experts backed wider use of Zyprexa, Seroquel, and Geodon expressing concern over long-term effects in younger patients. ...

Solvay challenged in US on male hormone therapy 12:11 PM 6/10/2009
Reuters - USA
Solvay said rival Perrigo Israel Pharmaceuticals had applied for approval from the US FDA to sell a generic of Solvay's Androgel treatment for testosterone deficiency. ...

Daiichi Sankyo Seeks Biotechnology, Cardiovascular Takeovers 6:37 AM 6/10/2009
Bloomberg - USA
Daiichi Sankyo Co is seeking biotechnology acquisitions in Europe tapping $5 billion to enter new markets and broaden its heart-drug portfolio. ...

Rigel arthritis drug poised to compete 12:55 PM 6/9/2009
Forbes - NY,USA
Rigel Pharmaceuticals Inc's drug candidate R788 is currently in midstage clinical trials with study data expected in July. R788 could become a significant player in the rheumatoid arthritis market. ...

Vivus says obesity drug helps diabetics 4:52 PM 6/8/2009
Reuters - USA
Vivus Inc said that its experimental drug Qnexa improved blood sugar control through weight loss in obese patients with type 2 diabetes. ...

US lawmaker urges action on generic biotech drugs 12:32 PM 6/8/2009
Reuters - USA
House Energy and Commerce Committee Chairman Henry Waxman asked the Obama administration "to consider what steps can be taken under existing authority to prepare and even begin to use a pathway for generic biologics." Public safety be damned. ...

Roche diabetes drug to start late stage trial 8:31 AM 6/8/2009
Reuters - USA
Roche Holding AG's diabetes drug aleglitazar is in a class of drugs known as PPAR co-agonists affecting both glucose and fat control. It appears to be safe and well tolerated. ...

Alnylam, Cubist say respiratory drug meets main goal 8:01 AM 6/8/2009
Reuters - USA
Alnylam Pharmaceuticals and Cubist Pharmaceuticals said their experimental drug ALN-RSV01 to treat respiratory infection met the main goal in a mid-stage study of respiratory syncytial virus (RSV). ...

Dyax says FDA accepts genetic-disease drug response 7:41 AM 6/8/2009
Reuters - USA
Dyax Corp said the US FDA has accepted the complete response submission for its experimental treatment ecallantide for a rare genetic disease. ...

Novartis moves cancer drug into new lymphoma study 5:14 AM 6/8/2009
Reuters - USA
Novartis' Afinitor cut tumor size by 50 percent in patients with lymphoma in a mid-stage clinical trial. A late-stage trial was started to evaluate the potential to extend disease-free survival in patients with diffuse large B-cell lymphoma (DLBCL). ...

Glaxo, Novartis, Roche, Lilly back biotech Aileron 2:12 AM 6/8/2009
Reuters - USA
The venture arms of GlaxoSmithKline, Novartis, Roche, and Eli Lilly are investing in biotech Aileron Therapeutics. ...

Lundbeck says might postpone US drug application 1:35 AM 6/8/2009
Reuters - USA
Lundbeck might postpone submission of the new drug application (NDA) in the US for anti-depression drug candidate Lu AA21004. ...

Biotechnology company says it can diagnose disease faster 2:03 PM 6/7/2009
Forbes - NY,USA
Biotechnology firm Beacon Biotechnology is seeking funding to broaden tests of a disposable computer chip that uses a single drop of body fluid to detect up to 112 diseases or genetic conditions in as little as 15 minutes. ...

<- Day Earlier | Today's News